Skip to content

AMLX - Amylyx Pharmaceuticals, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Amylyx Pharmaceuticals Inc

AMLX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

AMLXAmylyx Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $39.07
52-wk low: $8.46
Prev close: $23.11
Mkt cap: $3.91B
Fwd P/E: 2.8x
Beta: -0.20

Smart money

8 funds hold a position and insiders are trading both ways.

Real smart money

Funds holding this stock

8 holders

Combined position$590.6M

BA
Balyasny
Dmitry Balyasny · Q2 2026 13F
$12.3M
position
QR
Qube Research

Earnings

Reported Aug 6, 2026

Earnings came in 8.3% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 2.77
Market cap: $3.9B

Valuation

P/S0.66
P/B10.00

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: AMLX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $3.91B
Beta: -0.20

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

0.7x

P/B

10.0x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-74.7%

Q2 2026 13F

$12.2M

position

TS

Two Sigma

Q2 2026 13F

$10.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for AMLX

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.39-8.3%

-$0.36 expected

Next report

What the street expects next

EPS expected

-$0.37

-$0.42 to -$0.33

Revenue expected

$46.2K

9 analysts

Last 30 days

3up2down

Analysts raising estimates

Estimate drift

0.03

Change in 30 days

-74.7%

ROA-44.1%

Growth

Beta-0.20